The medical landscape is being poised for significant advancement in 2025, with several innovative therapies targeting previously challenging conditions. Let’s explore these promising treatments that could transform patient care. Targeted Cancer Treatment BreakthroughsLeading the charge is Telisotzumab vedotin from AbbVie, an antibody-drug conjugate designed specifically for non-small cell lung cancer patients with c-MET protein overexpression.